Role of Macrophages in Liver Fibrosis

被引:0
作者
Sun, Cuiming [1 ,2 ]
Matsukawa, Akihiro [1 ]
机构
[1] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Pathol & Expt Med, Okayama 7008558, Japan
[2] China Med Univ, Hosp 1, Dept Infect Dis, Shenyang, Liaoning, Peoples R China
关键词
ERK-MAPK; SPRED2; fibrosis; macrophages; HEPATIC STELLATE CELLS; TISSUE GROWTH-FACTOR; PHARMACOLOGICAL INHIBITION; INTERSTITIAL COLLAGENASE; ALTERNATIVE ACTIVATION; DENDRITIC CELLS; KUPFFER CELLS; EXPRESSION; MONOCYTES; DISTINCT;
D O I
暂无
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Liver fibrosis, which ultimately leads to liver cirrhosis and hepatocellular carcinoma, is a major health burden worldwide. The progression of liver fibrosis is the result of the wound-healing response of liver to repeated injury. Hepatic macrophages are cells with high heterogeneity and plasticity and include tissue-resident macrophages termed Kupffer cells, and recruited macrophages derived from circulating monocytes, spleen and peritoneal cavity. Studies have shown that hepatic macrophages play roles in the initiation and progression of liver fibrosis by releasing inflammatory cytokines/chemokines and pro-fibrogenic factors. Furthermore, the development of liver fibrosis has been shown to be reversible. Hepatic macrophages have been shown to alternately regulate both the regression and turnover of liver fibrosis by changing their phenotypes during the dynamic progression of liver fibrosis. In this review, we summarize the role of hepatic macrophages in the progression and regression of liver fibrosis.
引用
收藏
页码:1 / 8
页数:8
相关论文
共 70 条
[31]   Liver inflammation and fibrosis [J].
Koyama, Yukinori ;
Brenner, David A. .
JOURNAL OF CLINICAL INVESTIGATION, 2017, 127 (01) :55-64
[32]   Therapeutic inhibition of inflammatory monocyte recruitment reduces steatohepatitis and liver fibrosis [J].
Krenkel, Oliver ;
Puengel, Tobias ;
Govaere, Olivier ;
Abdallah, Ali T. ;
Mossanen, Jana C. ;
Kohlhepp, Marlene ;
Liepelt, Anke ;
Lefebvre, Eric ;
Luedde, Tom ;
Hellerbrand, Claus ;
Weiskirchen, Ralf ;
Longerich, Thomas ;
Costa, Ivan G. ;
Anstee, Quentin M. ;
Trautwein, Christian ;
Tacke, Frank .
HEPATOLOGY, 2018, 67 (04) :1270-1283
[33]   Liver macrophages in tissue homeostasis and disease [J].
Krenkel, Oliver ;
Tacke, Frank .
NATURE REVIEWS IMMUNOLOGY, 2017, 17 (05) :306-321
[34]   IL-33 Amplifies the Polarization of Alternatively Activated Macrophages That Contribute to Airway Inflammation [J].
Kurowska-Stolarska, Mariola ;
Stolarski, Bartosz ;
Kewin, Peter ;
Murphy, Grace ;
Corrigan, Christopher J. ;
Ying, Sun ;
Pitman, Nick ;
Mirchandani, Ananda ;
Rana, Batika ;
van Rooijen, Nico ;
Shepherd, Malcolm ;
McSharry, Charlie ;
McInnes, Iain B. ;
Xu, Damo ;
Liew, Foo Y. .
JOURNAL OF IMMUNOLOGY, 2009, 183 (10) :6469-6477
[35]   The Spleen Promotes the Secretion of CCL2 and Supports an M1 Dominant Phenotype in Hepatic Macrophages During Liver Fibrosis [J].
Li, Liang ;
Wei, Wei ;
Li, Zhenzhen ;
Chen, Haiyan ;
Li, Yu ;
Jiang, Wei ;
Chen, Weisan ;
Kong, Guangyao ;
Yang, Jun ;
Li, Zongfang .
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY, 2018, 51 (02) :557-574
[36]   Monocyte subsets in human liver disease show distinct phenotypic and functional characteristics [J].
Liaskou, Evaggelia ;
Zimmermann, Henning W. ;
Li, Ka-Kit ;
Oo, Ye H. ;
Suresh, Shankar ;
Stamataki, Zania ;
Qureshi, Omar ;
Lalor, Patricia F. ;
Shaw, Jean ;
Syn, Wing-kin ;
Curbishley, Stuart M. ;
Adams, David H. .
HEPATOLOGY, 2013, 57 (01) :385-398
[37]  
Maher J J, 1993, Semin Cell Biol, V4, P189, DOI 10.1006/scel.1993.1023
[38]   Roles for Chemokines in Liver Disease [J].
Marra, Fabio ;
Tacke, Frank .
GASTROENTEROLOGY, 2014, 147 (03) :577-+
[39]  
Martinez Fernando O, 2014, F1000Prime Rep, V6, P13, DOI 10.12703/P6-13
[40]   Fate tracing reveals hepatic stellate cells as dominant contributors to liver fibrosis independent of its aetiology [J].
Mederacke, Ingmar ;
Hsu, Christine C. ;
Troeger, Juliane S. ;
Huebener, Peter ;
Mu, Xueru ;
Dapito, Dianne H. ;
Pradere, Jean-Philippe ;
Schwabe, Robert F. .
NATURE COMMUNICATIONS, 2013, 4